Company Profile
Arcus Biosciences Stock Price, News & Analysis
- Ticker:
- RCUS
- Exchange:
- NYSE
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NYSE, Arcus Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
28.18 USD (+3.49%)
Close
Last updated: June 23, 2026 at 00:00
3.54B USD
Market cap
Why the stock is moving
RCUS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Arcus Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Arcus Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Arcus Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Arcus Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Arcus Biosciences (RCUS)?
Arcus Biosciences (RCUS) most recently closed at 28.18 USD, a +3.49% move versus the previous session.
What is the market cap of Arcus Biosciences (RCUS)?
Arcus Biosciences currently has a market capitalization of 3.54B USD on BioPharmSignal.
What does Arcus Biosciences do?
Arcus Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is RCUS stock listed?
Arcus Biosciences (RCUS) is associated with NYSE, Headquartered in the United States and listed on NYSE, Arcus Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Arcus?
Arcus Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Arcus Biosciences targeting with Arcus?
Arcus Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biosciences?
Arcus Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.